Tag: drug

Unraveling how much of a prescription drug price gets swallowed by “middlemen” is at the forefront of Tuesday’s drug price hearing in the Senate. One thing bound to come up: rebates. Both major political parties have shown interest in remedying high drug prices, and drugmakers have bemoaned how rebates...
Two drugmakers have submitted an approval application to the Food and Drug Administration for a drug to treat a rare blood disorder and a type of blood cancer. Cambridge, Massachusetts-based Acceleron Pharma and Summit, New Jersey-based Celgene said Friday that they had submitted a Biologics License Application to the...
FDA
Outgoing Food and Drug Administration Commissioner Scott Gottlieb may have been the most aggressive of all FDA leaders in addressing the problem of rising drug costs, albeit within the limited scope of his authority to address the issue. Now, he’s taking that initiative into the private sector. Gottlieb will...
A partnership between a large British drugmaker and a startup that discovers drugs using artificial intelligence has borne fruit. Oxford, UK-based Exscientia said Wednesday that it had delivered the first drug candidate to be found using its AI collaboration with GlaxoSmithKline, a potential therapy for chronic obstructive pulmonary disorder,...
After Thursday’s halt to aducanumab’s development dealt a significant blow to the amyloid beta hypothesis in Alzheimer’s, analysts had expected BAN 2401 – developed under a partnership with Biogen – to be shelved as well. Source link
Dementia or brain damage and injury as a mental health and neurology medical symbol with a thinking human organ made of crumpled paper torn in pieces as a creative concept for alzheimer disease.
The news sent Biogen’s shares down more than 26 percent pre-market, but analysts also wrote that it deals a significant blow to amyloid beta as a target in Alzheimer’s disease. Source link
A company developing an oral therapy for sickle cell disease has raised more than $60 million in its second major round of financing from several US-based and European investors. Cambridge, Massachusetts-based Imara said Monday that it had raised the $63 million Series B funding round, led by new investors...
Behind companies like Hims, Nurx and Lemonaid sits Truepill’s technology, which handles the logistics, shipping and pharmacy fulfillment necessary to run the direct-to-consumer businesses. Source link
Roche’s headquarters in Basel, Switzerland The Food and Drug Administration has approved the first ever immunotherapy regimen for breast cancer. Swiss drugmaker Roche said Monday that the FDA had granted accelerated approval to the PD-L1 checkpoint inhibitor Tecentriq (atezolizumab), combined with Celgene’s Abraxane (nab-paclitaxel), for triple-negative breast cancer that cannot...
Although he’s barely into a seven-year prison sentence, the smell of money is still too much for former pharmaceutical executive Martin Shkreli to resist. Citing interviews with multiple unnamed sources, The Wall Street Journal reported Thursday that Shkreli uses a contraband mobile phone to control his latest project, Phoenixus,...
0FansLike
0FollowersFollow

Latest Posts